Defining high risk and ultra-high risk MM

Speaker(s)

• 

  Martin F. Kaiser, MD, FRCP, FRCPath

  Consultant Haematologist
  The Institute of Cancer Research; Royal Marsden Hospital
  Sutton, England, United Kingdom